Taiwan's novel pharma products hit by low reimbursement prices | Healthcare Asia Magazine
, Taiwan

Taiwan's novel pharma products hit by low reimbursement prices

The low rates are discouraging the launch of new innovative products, insiders say.

While innovation is recognised in Taiwan, novel pharmaceutical products in the country will continue to see constraints to their growth prospects, due to the impact of the insurance system on drug prices, especially for new and innovative medicines, according to Fitch Solutions.

Taiwan has raised its health insurance premiums from 4.69% to 5.17% and supplemental premiums from 1.91% to 2.11%, informed by a rise in elderly population. Between 2000 and February 2021, the percentage of the population over 65 nearly doubled from just under 9% to 16% while the proportion of 0-14 year olds nearly halved from 21% to 12.5%.

Still, the report noted that reimbursement prices in the country tend to be much lower than in OECD countries because of the government’s single-payer status, and the hospitals typically negotiate with the pharmaceutical companies for discounts. This discourages the launch of new innovative products in Taiwan.

For instance, two medications recently left the market. A pharma company announced that it will stop selling the antidepressant Prozac as of April 2019, whilst another ceased providing the antibiotic Tienam.

“Another impact of the low reimbursement prices is that new drugs tend to be launched in Taiwan much later than certain other markets,” the report added.

Join Healthcare Asia Magazine community
Since you're here...

...there are many ways you can work with us to advertise your company and connect to your customers. Our team can help you dight and create an advertising campaign, in print and digital, on this website and in print magazine.

We can also organize a real life or digital event for you and find thought leader speakers as well as industry leaders, who could be your potential partners, to join the event. We also run some awards programmes which give you an opportunity to be recognized for your achievements during the year and you can join this as a participant or a sponsor.

Let us help you drive your business forward with a good partnership!


CHI accelerates the development and adoption of health tech firm innovations
The Centre for Healthcare Innovation invests $2.4m (US1.8m) to set a framework that can test the safety of market-ready innovations.
Catholic Medical Center trailblazing big data and AI adoption in Korean healthcare
Its flagship Seoul St. Mary’s Hospital leads the seamless integration of cutting-edge technology across CMC’s eight affiliate hospitals.
OUE Healthcare poised to capture foreign patient demand for specialist care services
The healthcare group recently partnered with three medical specialist groups including two leading respiratory and cardiothoracic surgery specialist practices.
iClaim boosts Thailand’s health insurance claims in 10 seconds
IT expert Piyawat Maneenual sets up a game-changing platform that allows data transfer from hospitals to insurance companies in real-time.